Literature DB >> 20846560

Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy.

Christopher K Fuller, John A Charlson, Steven K Dankle, Thomas J Russell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846560     DOI: 10.1016/j.jaad.2009.09.035

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  16 in total

Review 1.  Cryoimmunology for malignant bone and soft-tissue tumors.

Authors:  Hideji Nishida; Norio Yamamoto; Yoshikazu Tanzawa; Hiroyuki Tsuchiya
Journal:  Int J Clin Oncol       Date:  2011-03-12       Impact factor: 3.402

2.  Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions.

Authors:  Emanuela Palmerini; Robert G Maki; Eric L Staals; Marco Alberghini; Cristina R Antonescu; Crisitina Ferrari; Pietro Ruggieri; Andreas Mavrogenis; Franco Bertoni; Marilena Cesari; Anna Paioli; Emanuela Marchesi; Piero Picci; Stefano Ferrari
Journal:  Am J Clin Oncol       Date:  2014-12       Impact factor: 2.339

3.  Efficacy of Tie2 receptor antagonism in angiosarcoma.

Authors:  Jason R Hasenstein; Kelsey Kasmerchak; Darya Buehler; Gholam Reza Hafez; Kevin Cleary; John S Moody; Kevin R Kozak
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

4.  Thalidomide combined with neoadjuvant chemotherapy in angiosarcoma of the breast with complete pathologic response: case report and review of literature.

Authors:  Alberto Alvarado-Miranda; Ludwing Bacon-Fonseca; Fernando Ulises Lara-Medina; Hector Maldonado-Martínez; Claudia Arce-Salinas
Journal:  Breast Care (Basel)       Date:  2013-03       Impact factor: 2.860

5.  Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: a case report and review of literature.

Authors:  Ping Yang; Qi Zhu; Fuqiang Jiang
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

Review 6.  Emerging therapeutic targets for soft tissue sarcoma.

Authors:  Jason L Smith; Richard F Riedel
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

7.  A Recurrent Angiosarcoma Isolated to the Eyelid without the Recurrence on the Primary Lesion of the Forehead.

Authors:  Jung Eun Kim; Byung Jik Kim; Hoon Kang
Journal:  Ann Dermatol       Date:  2014-04-30       Impact factor: 1.444

8.  Angiosarcoma presenting with minor erythema and swelling.

Authors:  Catherine A Cox; Richard O Wein; Roya Ghafouri; Nora M Laver; Katrinka L Heher; Mitesh K Kapadia
Journal:  Case Rep Ophthalmol       Date:  2013-04-05

9.  New drugs and combinations for the treatment of soft-tissue sarcoma: a review.

Authors:  Neeta Somaiah; Margaret von Mehren
Journal:  Cancer Manag Res       Date:  2012-11-23       Impact factor: 3.989

10.  Primary calvarial angiosarcoma: A case report and review of the literature.

Authors:  Imad S Khan; Jai D Thakur; Osama Ahmed; Cedric D Shorter; Jaiyeola Thomas-Ogunniyl; Mary T Kim; Majed A Jeroudi; Bharat Guthikonda
Journal:  Surg Neurol Int       Date:  2012-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.